Health groups defend Down's test patent challenge
This article was originally published in Clinica
Executive Summary
A consortium of US healthcare groups has formed a legal defence fund to help Kaiser Permanente challenge a company seeking royalties on a commonly-used prenatal test for Down's syndrome.